NO996438L - New combination of anti-asthma drugs - Google Patents

New combination of anti-asthma drugs

Info

Publication number
NO996438L
NO996438L NO996438A NO996438A NO996438L NO 996438 L NO996438 L NO 996438L NO 996438 A NO996438 A NO 996438A NO 996438 A NO996438 A NO 996438A NO 996438 L NO996438 L NO 996438L
Authority
NO
Norway
Prior art keywords
new combination
asthma drugs
kit
active ingredient
asthma
Prior art date
Application number
NO996438A
Other languages
Norwegian (no)
Other versions
NO996438D0 (en
Inventor
Bengt Axelsson
Leif Kollstroem
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO996438D0 publication Critical patent/NO996438D0/en
Publication of NO996438L publication Critical patent/NO996438L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Preparat eller kit som har som en første aktiv bestanddel formoterol, eller et salt eller solvatderivat derav, og som har som en annen aktiv bestanddel rofleponid, eller en fett- syreester derav. Det er også beskrevet fremgangsmåter for behandling av respiratoriske forstyrrelser ved anvendelse av nevnte preparat eller kit.A composition or kit having as a first active ingredient formoterol, or a salt or solvate derivative thereof, and having as a second active ingredient rofleponide, or a fatty acid ester thereof. Methods are also described for treating respiratory disorders using said preparation or kit.

NO996438A 1997-06-27 1999-12-23 New combination of anti-asthma drugs NO996438L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88382397A 1997-06-27 1997-06-27
PCT/SE1998/001089 WO1999000134A1 (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments

Publications (2)

Publication Number Publication Date
NO996438D0 NO996438D0 (en) 1999-12-23
NO996438L true NO996438L (en) 2000-02-28

Family

ID=25383399

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996438A NO996438L (en) 1997-06-27 1999-12-23 New combination of anti-asthma drugs

Country Status (16)

Country Link
EP (1) EP1009408A1 (en)
JP (1) JP2002510310A (en)
KR (1) KR20010014162A (en)
AU (1) AU8135098A (en)
BR (1) BR9810452A (en)
CA (1) CA2295076A1 (en)
EE (1) EE9900594A (en)
HU (1) HUP0002533A3 (en)
ID (1) ID24063A (en)
IL (1) IL133597A0 (en)
IS (1) IS5303A (en)
NO (1) NO996438L (en)
PL (1) PL337722A1 (en)
SK (1) SK184799A3 (en)
TR (1) TR199903272T2 (en)
WO (1) WO1999000134A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (en) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (en) 1998-06-11 1998-06-11 Astra Ab New use
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
SE9900833D0 (en) * 1999-03-09 1999-03-09 Astra Ab Novel combination
GB0009617D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
WO2004028545A1 (en) * 2002-09-25 2004-04-08 Astrazeneca Ab A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (en) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SG48301A1 (en) * 1991-12-18 1998-04-17 Astra Ab New combination
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation
SE9501384D0 (en) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
SE9603669D0 (en) * 1996-10-08 1996-10-08 Astra Ab New combination

Also Published As

Publication number Publication date
EP1009408A1 (en) 2000-06-21
AU8135098A (en) 1999-01-19
EE9900594A (en) 2000-08-15
HUP0002533A3 (en) 2001-03-28
NO996438D0 (en) 1999-12-23
IL133597A0 (en) 2001-04-30
BR9810452A (en) 2000-09-05
IS5303A (en) 1999-12-15
HUP0002533A2 (en) 2000-12-28
ID24063A (en) 2000-07-06
KR20010014162A (en) 2001-02-26
CA2295076A1 (en) 1999-01-07
WO1999000134A1 (en) 1999-01-07
PL337722A1 (en) 2000-08-28
TR199903272T2 (en) 2000-08-21
JP2002510310A (en) 2002-04-02
SK184799A3 (en) 2000-06-12

Similar Documents

Publication Publication Date Title
NO950774L (en) Method of inhibiting bone loss and lowering serum cholesterol
NO982414L (en) New combination
NO20005431L (en) Gellable pharmaceutical preparations
HUP0104718A2 (en) Micronized eplerenone compositions and process for their preparation
NO20080284L (en) Cannabionoid active pharmaceutical ingredient for improved dosage forms
BR0206381A (en) Fumaric acid derivatives as nf-kappab inhibitor
NO951498L (en) Pharmaceutical preparation for the treatment of osteoporosis
BRPI0412526A (en) compound, use of a compound, pharmaceutical composition, pharmaceutical aerosol formulation, and method for treating a human or animal patient with an anti-inflammatory and / or allergic condition
HUP0104258A2 (en) Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
BRPI0413490A (en) new compounds
NO20076019L (en) Outer skin preparation
NO20034751L (en) Anthranilic acid amides, their preparation and use as well as preparations
BRPI0408990A (en) pyrimidin-4-one derivatives and their use as p38 kinase modulators
NO20032734D0 (en) New 1,2-diphenyllazetidinone derivatives, process for their preparation, drugs containing said compounds and use of these for the treatment of diseases from lipid metabolism
DE59509751D1 (en) AGING EFFECTS AGAINST SKIN AGING OR ACTIVE SUBSTANCE COMBINATIONS AND PREPARATIONS
BRPI0312464B8 (en) tyrosine kinase inhibitor compounds, pharmaceutical compositions comprising them, processes for manufacturing and uses thereof
CA2213989A1 (en) External preparation for topical administration
BR0211673A (en) Dermal therapy using phosphate derivatives of electron transfer agents
BRPI0411255A (en) compound, pharmaceutical composition, use of a compound, methods of treating a disorder of a patient, and process for the preparation of a compound
HUP0004396A2 (en) Pharmaceutical compositions containing hydroxylated cholesterol lowering agent as inhibitor of lipoprotein oxidation
PT99597B (en) METHOD FOR THE PREPARATION OF HYDROXAMIC ACID DERIVATIVES THAT INHIBITS LIPOXYGENASE
EP0727217A3 (en) Pharmaceutical and cosmetic compositions containing ellagitannin of the god type as active ingredient
BR0314797A (en) Pyrimidineamide derivatives and their use
NO20006430L (en) Neuroprotective composition for the prevention and / or treatment of nerve and behavioral changes due to anxiety or depression
PA8559401A1 (en) SUCCINIC ACID SALTS OF 5,7,14-TRIAZATETRACICLO (10.3.1.0 2,11.0 4, 9) -HEXADECA-2 (11), 3,5,7,9-PENTAENO AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application